The Letter of the Final Batch
On the day the final production batch ends at a long-running pharmaceutical ingredient plant, a process supervisor near retirement and a junior colleague about to move on have a conversation they haven't had yet.
The batch number was BK-2847.
Oh Taehyeon read the twelve digits three times without speaking. The handwriting on the inspection card taped to the reactor was his. For thirty-one years, he had opened and closed thousands of batches in this plant. He had never thought about what number the last one would be. 2847 carried no particular weight—neither light nor heavy.
Lim Sua walked over with a sampling tube toward the reactor. She was moving to a larger CDMO in South Chungcheong Province in three months. Taehyeon had known this before she said it. When a person packs, their footsteps change.
“Is the temperature right, senior?”
“41.3 degrees. Same as yesterday.”
Sua wrote something down and clipped the clipboard to her side. The reactor made a low, even sound. Taehyeon had stopped really hearing it long ago. After thirty years, background noise becomes just that.
This plant, Miram Biochem, was not shutting down on executive whim. It was the culmination of three years of planned restructuring. The thinning out of small-batch plants was an industry-wide current. Larger CDMOs had brought in continuous-process lines, and the unit cost of running twelve reactors in a small facility no longer made sense. Taehyeon had understood this before any report arrived. Production volumes crept down, capital requests stopped, and then the report came.
“What will you make there?”
Taehyeon spoke first. For him, this was reaching out.
“Cardiovascular ingredients. I don’t know the exact compounds yet.”
“That place has big reactors.”
“Yeah. Ten times the capacity of here.”
Taehyeon looked at the reactor wall again after hearing that. Bigger capacity sounds like a good thing. But most reactors in this world had already been used by someone else. The big reactor Sua was going to, someone long ago had been the first to dial in its temperature.
“When the final sample comes back from QC, is that the end of the day?”
“Usually takes two hours after pass.”
Sua set her clipboard on the shelf above the reactor and walked toward the window. The factory windows were small and high, showing only a sliver of sky. Taehyeon remembered that the proportions had been exactly like this since the day he was first assigned here.
“What about you, senior? What will you do after?”
“After.”
Taehyeon repeated the word once.
“Nothing special. I have a garden at home. My wife always said she did it alone. I thought I’d help her with that.”
Sua turned from the window. Her face held something more she wanted to ask but chose not to. Taehyeon recognized that expression too. After thirty years, a person starts to read faces.
The final reaction in batch BK-2847 stopped an hour and a half later. The sample went to QC, and Taehyeon wrote the stop time in the log below. Sua watched him do it.
“Where does this ingredient go?”
“A finished pharmaceutical company in Europe. They’ll make an antibiotic with it.”
Sua said nothing. Taehyeon said nothing more. When the reactor sound stopped completely, the factory felt a little larger somehow. He knew it was a trick of the mind, but he felt it anyway.
The ingredient was scheduled to ship that evening. Somewhere in someone’s body, something would be blocked or opened. After the reactor stopped, the molecules kept moving. Taehyeon realized that day, for the first time, that this was one of the few consolations of his entire working life. But he said nothing. Sua seemed to know it already.
This article is for information only and is not investment advice.